Lisa Delfini, Chief Financial Officer at Trevi Therapeutics, Inc. (TRVI), sold 4,350 shares at $2.64 ($11K) on 2024-05-22, disclosed to the SEC on 2024-05-24.
Open-market sale of $11k TRVI by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TRVI | SELL | 2023-08-14 | $2K | — | Filing → |
| TRVI | SELL | 2023-07-12 | $2K | — | Filing → |
| TRVI | SELL | 2023-06-14 | $2K | — | Filing → |